Explore Products
Tumor Cell Lines

DMS 454

  • BSL

    1

  • 214
Human Caucasian lung, small cell carcinoma. The small cell carcinoma DMS 454 was isolated in 1981 from lung tissue of a male patient at time of autopsy. The cells contain dense-core vesicles and secrete calcitonin.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Product Code

DMS-454; DMS454

Species

Human

Cat.No

ABC-TC0215

Product Category Tumor Cell Lines
Size/Quantity

1 vial

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Lung

Disease

Lung Small Cell Cancer

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Human Lung Cancer Cell Lines

Description

DMS-454
DMS-454 is a human small cell lung carcinoma (SCLC) cell line established from the lung tissue of a Caucasian male patient during autopsy. It displays polygonal morphology with adherent growth characteristics and contains dense-core vesicles, secreting calcitonin, indicating neuroendocrine features common to SCLC. The cells can be cultured in Waymouth’s MB 752/1 medium supplemented with 2mM glutamine and 10% fetal bovine serum (FBS), or alternatively in RPMI 1640 with 10% FBS [1]. Routine subculture involves digestion with 0.25% trypsin or trypsin/EDTA and a 1:3 split ratio when cultures reach sub-confluence. Cytogenetic analysis has not been extensively reported, and specific gene mutations remain undefined. However, DMS-454 shares key biological behaviors with other SCLC lines, including likely tumorigenicity and high metastatic potential based on the aggressive nature of its tumor origin. It is suitable for studies on neuroendocrine tumor biology and calcitonin-secreting carcinomas.
View Product Image

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

  • DMS-454 is a valuable model for studying small-cell lung cancer and developing new therapies for these patients. For example, the utilization of DMS-454 provides an opportunity to identify the tumor markers specific to small cell lung cancer (SCLC) in the initial stage. Once these markers are identified, the next step involves assessing the effectiveness of antibodies targeting these markers within the context of CAR-T cell therapy. This approach aims to determine whether the antibodies can effectively engage the markers and initiate the desired immune response to eliminate cancer cells.

Inquiring DMS 454

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button